Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness

E. Towpik, J. W. Kupiec-Weglinski, T. M. Schneider, Douglas Tyler, W. Padberg, D. Araneda, N. L. Tilney

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Immunological unresponsiveness toward skin allografts was studied in cyclosporine (CsA)-treated rats. BN skin grafts survive about 22 days and about 34 days in LEW hosts following 7 or 14 days of daily CsA treatment (15 mg/kg/day), respectively; in unmodified hosts grafts are rejected by 9 days. Indefinite (>100 days) survival can, however, be produced by administering maintenance 15 mg/kg CsA every fourth day, following an initial course of the agent for 14 days. Early signs of graft rejection (hair loss, localized epidermal breakdown, and ulcerations) occurring in some animals were reversed by a CsA 'pulse' (15 mg/kg/day) for 7 days, reduced gradually to the maintenance dose. CsA was equally effective when started as late as 4 days after grafting, but ineffectual when started after day 4. Once BN grafts were rejected, the agent could not prevent second-set rejection of donor-specific grafts, but significantly prolonged the survival of third-party (WF) skins. Survival of original BN grafts was unchanged by the placement of second BN grafts during both the inductive and maintenance phases; these second grafts survived as long as the original grafts. In contrast, secondary third-party (WF) grafts were promptly rejected; their destruction did not influence survival of the original grafts. Thus, indefinite survival of rat skin allografts is feasible with low maintenance doses of CsA. Graft rejection at later stages can be reversed by resuming daily therapy. Host unresponsiveness is stable and specific both during the early inductive and later maintenance phases.

Original languageEnglish (US)
Pages (from-to)714-718
Number of pages5
JournalTransplantation
Volume40
Issue number6
StatePublished - 1985
Externally publishedYes

Fingerprint

Cyclosporine
Allografts
Transplants
Skin
Maintenance
Graft Rejection
Alopecia
Graft Survival

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Towpik, E., Kupiec-Weglinski, J. W., Schneider, T. M., Tyler, D., Padberg, W., Araneda, D., & Tilney, N. L. (1985). Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness. Transplantation, 40(6), 714-718.

Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness. / Towpik, E.; Kupiec-Weglinski, J. W.; Schneider, T. M.; Tyler, Douglas; Padberg, W.; Araneda, D.; Tilney, N. L.

In: Transplantation, Vol. 40, No. 6, 1985, p. 714-718.

Research output: Contribution to journalArticle

Towpik, E, Kupiec-Weglinski, JW, Schneider, TM, Tyler, D, Padberg, W, Araneda, D & Tilney, NL 1985, 'Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness', Transplantation, vol. 40, no. 6, pp. 714-718.
Towpik, E. ; Kupiec-Weglinski, J. W. ; Schneider, T. M. ; Tyler, Douglas ; Padberg, W. ; Araneda, D. ; Tilney, N. L. / Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness. In: Transplantation. 1985 ; Vol. 40, No. 6. pp. 714-718.
@article{a712c9c445a94554b95a87c2312ccbf7,
title = "Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness",
abstract = "Immunological unresponsiveness toward skin allografts was studied in cyclosporine (CsA)-treated rats. BN skin grafts survive about 22 days and about 34 days in LEW hosts following 7 or 14 days of daily CsA treatment (15 mg/kg/day), respectively; in unmodified hosts grafts are rejected by 9 days. Indefinite (>100 days) survival can, however, be produced by administering maintenance 15 mg/kg CsA every fourth day, following an initial course of the agent for 14 days. Early signs of graft rejection (hair loss, localized epidermal breakdown, and ulcerations) occurring in some animals were reversed by a CsA 'pulse' (15 mg/kg/day) for 7 days, reduced gradually to the maintenance dose. CsA was equally effective when started as late as 4 days after grafting, but ineffectual when started after day 4. Once BN grafts were rejected, the agent could not prevent second-set rejection of donor-specific grafts, but significantly prolonged the survival of third-party (WF) skins. Survival of original BN grafts was unchanged by the placement of second BN grafts during both the inductive and maintenance phases; these second grafts survived as long as the original grafts. In contrast, secondary third-party (WF) grafts were promptly rejected; their destruction did not influence survival of the original grafts. Thus, indefinite survival of rat skin allografts is feasible with low maintenance doses of CsA. Graft rejection at later stages can be reversed by resuming daily therapy. Host unresponsiveness is stable and specific both during the early inductive and later maintenance phases.",
author = "E. Towpik and Kupiec-Weglinski, {J. W.} and Schneider, {T. M.} and Douglas Tyler and W. Padberg and D. Araneda and Tilney, {N. L.}",
year = "1985",
language = "English (US)",
volume = "40",
pages = "714--718",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness

AU - Towpik, E.

AU - Kupiec-Weglinski, J. W.

AU - Schneider, T. M.

AU - Tyler, Douglas

AU - Padberg, W.

AU - Araneda, D.

AU - Tilney, N. L.

PY - 1985

Y1 - 1985

N2 - Immunological unresponsiveness toward skin allografts was studied in cyclosporine (CsA)-treated rats. BN skin grafts survive about 22 days and about 34 days in LEW hosts following 7 or 14 days of daily CsA treatment (15 mg/kg/day), respectively; in unmodified hosts grafts are rejected by 9 days. Indefinite (>100 days) survival can, however, be produced by administering maintenance 15 mg/kg CsA every fourth day, following an initial course of the agent for 14 days. Early signs of graft rejection (hair loss, localized epidermal breakdown, and ulcerations) occurring in some animals were reversed by a CsA 'pulse' (15 mg/kg/day) for 7 days, reduced gradually to the maintenance dose. CsA was equally effective when started as late as 4 days after grafting, but ineffectual when started after day 4. Once BN grafts were rejected, the agent could not prevent second-set rejection of donor-specific grafts, but significantly prolonged the survival of third-party (WF) skins. Survival of original BN grafts was unchanged by the placement of second BN grafts during both the inductive and maintenance phases; these second grafts survived as long as the original grafts. In contrast, secondary third-party (WF) grafts were promptly rejected; their destruction did not influence survival of the original grafts. Thus, indefinite survival of rat skin allografts is feasible with low maintenance doses of CsA. Graft rejection at later stages can be reversed by resuming daily therapy. Host unresponsiveness is stable and specific both during the early inductive and later maintenance phases.

AB - Immunological unresponsiveness toward skin allografts was studied in cyclosporine (CsA)-treated rats. BN skin grafts survive about 22 days and about 34 days in LEW hosts following 7 or 14 days of daily CsA treatment (15 mg/kg/day), respectively; in unmodified hosts grafts are rejected by 9 days. Indefinite (>100 days) survival can, however, be produced by administering maintenance 15 mg/kg CsA every fourth day, following an initial course of the agent for 14 days. Early signs of graft rejection (hair loss, localized epidermal breakdown, and ulcerations) occurring in some animals were reversed by a CsA 'pulse' (15 mg/kg/day) for 7 days, reduced gradually to the maintenance dose. CsA was equally effective when started as late as 4 days after grafting, but ineffectual when started after day 4. Once BN grafts were rejected, the agent could not prevent second-set rejection of donor-specific grafts, but significantly prolonged the survival of third-party (WF) skins. Survival of original BN grafts was unchanged by the placement of second BN grafts during both the inductive and maintenance phases; these second grafts survived as long as the original grafts. In contrast, secondary third-party (WF) grafts were promptly rejected; their destruction did not influence survival of the original grafts. Thus, indefinite survival of rat skin allografts is feasible with low maintenance doses of CsA. Graft rejection at later stages can be reversed by resuming daily therapy. Host unresponsiveness is stable and specific both during the early inductive and later maintenance phases.

UR - http://www.scopus.com/inward/record.url?scp=0022388695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022388695&partnerID=8YFLogxK

M3 - Article

VL - 40

SP - 714

EP - 718

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -